Expertise that unites real-world evidence and patient access to improve outcomes.
UBC brings together seasoned professionals specializing in specialty therapies across risk management, evidence development, and patient access. Providing collaborative, expert-driven solutions tailored to your program, we are driven by a commitment to overcoming the barriers between your therapy and the patients that need it most. We leverage unrivaled expertise, real-world data and the latest technologies to provide the insights you need to mitigate risk, demonstrate long-term product value, ensure access, and support better patient outcomes.tis, pulvinar dapibus leo.
Insights
Key Insights from the 2026 REMS Industry Consortium Annual Meeting
AI, standardization, and a shifting FDA landscape — here’s what the 2026 RIC Annual Meeting revealed about the future of REMS.
News
UBC Appoints Dr. Massoud Toussi as Vice President, Real World Evidence
UBC welcomes Massoud Toussi as its new Vice President of Real-World Evidence. Toussi brings over 20 years of experience spanning pharma, CROs, and regulatory work. He’s authored more than 50 publications and contributed to scientific standards through ENCePP, ISPE, ISPOR, and other key organizations.
Events
AAN Annual Meeting 2026
UBC is looking forward to attending the AAN Annual Meeting, the world’s largest gathering of neurologists and neuroscience professionals. Connect with our experts to learn how we deliver evidence development strategies, observational research, and risk management solutions that support patient safety and regulatory compliance for neurology programs.
A Better Start to Therapy
With streamlined enrollment options and real-time capabilities, including purpose-built patient access technology solutions, UBC brings a “no patient left behind” approach to the start of therapy.
A Better Start to Therapy
With streamlined enrollment options and real-time capabilities, including purpose-built patient access technology solutions, UBC brings a “no patient left behind” approach to the start of therapy.
A Better Start to Therapy
With streamlined enrollment options and real-time capabilities, including purpose-built patient access technology solutions, UBC brings a “no patient left behind” approach to the start of therapy.
A Better Start to Therapy
With streamlined enrollment options and real-time capabilities, including purpose-built patient access technology solutions, UBC brings a “no patient left behind” approach to the start of therapy.
A Better Start to Therapy
With streamlined enrollment options and real-time capabilities, including purpose-built patient access technology solutions, UBC brings a “no patient left behind” approach to the start of therapy.
A Better Start to Therapy
With streamlined enrollment options and real-time capabilities, including purpose-built patient access technology solutions, UBC brings a “no patient left behind” approach to the start of therapy.
A Better Start to Therapy
With streamlined enrollment options and real-time capabilities, including purpose-built patient access technology solutions, UBC brings a “no patient left behind” approach to the start of therapy.
